Literature DB >> 16217067

L-DOPS therapy for refractory orthostatic hypotension in autoimmune autonomic neuropathy.

Christopher H Gibbons1, Steven A Vernino, Horacio Kaufmann, Roy Freeman.   

Abstract

The authors report a 46-year-old woman with antibodies to the nicotinic acetylcholine receptor (NiAchR) of the autonomic ganglia. She presented with severe orthostatic intolerance refractory to treatment with midodrine, fludrocortisone, erythropoietin, vasopressin, salt, and fluid loading. Addition of L-threo-3,4-dihidroxyphenylserine (L-DOPS) substantially improved blood pressure and orthostatic tolerance. L-DOPS may benefit patients with severe orthostatic intolerance and be particularly effective in patients with ganglionic NiAchR antibodies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16217067     DOI: 10.1212/01.wnl.0000178980.83477.14

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

Review 1.  Management of neurogenic orthostatic hypotension: an update.

Authors:  Phillip A Low; Wolfgang Singer
Journal:  Lancet Neurol       Date:  2008-05       Impact factor: 44.182

2.  Autoimmune autonomic ganglionopathy with reversible cognitive impairment.

Authors:  Christopher H Gibbons; Justin Centi; Steven Vernino; Roy Freeman
Journal:  Arch Neurol       Date:  2011-12-12

Review 3.  Orthostatic Hypotension: Management of a Complex, But Common, Medical Problem.

Authors:  Artur Fedorowski; Fabrizio Ricci; Viktor Hamrefors; Kristin E Sandau; Tae Hwan Chung; James A S Muldowney; Rakesh Gopinathannair; Brian Olshansky
Journal:  Circ Arrhythm Electrophysiol       Date:  2022-02-25

Review 4.  The pathophysiology and diagnosis of orthostatic hypotension.

Authors:  David Robertson
Journal:  Clin Auton Res       Date:  2008-03-27       Impact factor: 4.435

Review 5.  L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience.

Authors:  Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2008-03-27       Impact factor: 4.435

6.  Autoimmune autonomic ganglionopathy: IgG effects on ganglionic acetylcholine receptor current.

Authors:  Z Wang; P A Low; J Jordan; R Freeman; C H Gibbons; C Schroeder; P Sandroni; S Vernino
Journal:  Neurology       Date:  2007-05-29       Impact factor: 9.910

Review 7.  Immune-mediated autonomic neuropathies.

Authors:  Mill Etienne; Louis H Weimer
Journal:  Curr Neurol Neurosci Rep       Date:  2006-01       Impact factor: 5.081

8.  Diagnostic treatment dilemma: baroreflex failure or autoimmune autonomic ganglionopathy?

Authors:  Maureen C Farrell; Alexander S Brenner; Cyndya A Shibao
Journal:  Clin Auton Res       Date:  2018-08-27       Impact factor: 4.435

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.